Here's what you need to know about the AstraZeneca 1:12 vaccine
(CNN Spanish) -
The National Administration of Medicines, Food and Medical Technology of Argentina (ANMAT) announced this Wednesday that it authorized the emergency registration of the AstraZeneca vaccine against covid-19.
Through a statement, the health entity indicated that this vaccine meets "an acceptable benefit-risk balance," which allowed the granting of registration.
The authorization is for a period of one year and will be under the condition of "sale under prescription."
MIRA: United Kingdom authorizes the Oxford / AstraZeneca vaccine against covid-19 and implements a new vaccination strategy
ANMAT communicated that a risk management plan must be complied with, in addition to communicating progress reports to the National Institute of Medicines (Iname).
Also this Wednesday, the AstraZeneca vaccine and the University of Oxford was approved by the regulatory authorities of the United Kingdom, a country that became the first to give it the endorsement.
This is the third vaccine against covid-19 that is authorized in Argentina, after that of Pfizer-BioNTech and Sputnik V, developed in Russia.
advertising
Argentina began on Tuesday to vaccinate health personnel with the product it acquired from Russia, Sputnik V.
MIRA: Argentina begins to apply the Russian Sputnik V vaccine against covid-19
As of Tuesday, the Argentine Ministry of Health confirmed one million 602,163 cases of covid-19 and 43,018 deaths linked to the virus.
